Table 1.

Effect of oral administration of CFW on the changes of the body weight and organ weight in PM_2.5-exposed SD rats.

Organ Weight (g)	Group
	Control	DED	CFW 200	CFW 400	Lutein	CsA
BW gain	31.92 ± 9.35	28.11 ± 9.03	31.13 ± 6.94	30.05 ± 8.07	30.48 ± 6.77	34.03 ± 10.04
Thymus	0.40 ± 0.08	0.39 ± 0.07	0.41 ± 0.06	0.42 ± 0.10	0.36 ± 0.04	0.38 ± 0.09
Heart	0.69 ± 0.04	0.68 ± 0.03	0.67 ± 0.04	0.65 ± 0.06	0.66 ± 0.02	0.67 ± 0.06
Lung	1.08 ± 0.09	1.02 ± 0.07	1.01 ±0.06	0.98 ±0.08	0.99 ± 0.06	1.01 ± 0.07
Liver	6.43 ± 0.47	6.47 ± 0.59	6.33 ± 0.68	6.28 ± 0.59	6.42 ± 0.88	6.44 ± 0.67
Kidney	1.52 ± 0.18	1.47± 0.11	1.49 ± 0.09	1.51 ± 0.14	1.45 ± 0.06	1.49 ± 0.12
Spleen	0.53 ± 0.04	0.52 ± 0.07	0.52 ± 0.07	0.53 ± 0.05	0.51 ± 0.08	0.54 ± 0.04
Uterus and Ovary	0.51 ± 0.10	0.48 ± 0.08	0.49 ± 0.11	0.52 ± 0.10	0.59 ± 0.18	0.58 ± 0.14

The data are expressed as mean ± standard deviation (n = 5). Control, untreated group; DED, PM_2.5 with normal saline-treated group; CFW 200, PM_2.5 with 200 mg/kg of water extracts of Corni Fructus-treated group; CFW 400, PM_2.5 with 400 mg/kg of water extracts of Corni Fructus-treated group; Lutein, PM_2.5 with lutein-treated group; and CsA, PM_2.5 with cyclosporine A-treated group. CsA, cyclosporin A.